BNP Paribas Financial Markets
STAB

BNP Paribas Financial Markets’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-41
Closed -$393 – 4331
2014
Q2 		$393 Hold
41
– – ﹤0.01% 3623
2014
Q1 		$508 Hold
41
– – ﹤0.01% 3040
2013
Q4 		$958 Buy
+41
New +$1.11K ﹤0.01% 3841

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's STAB Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2014, closing a stake of 41 shares — an estimated $393 sold.

BNP Paribas Financial Markets first reported a position in STAB in Q4 2013 and held it in 3 quarters. The position peaked at $958 in Q4 2013. 25 funds tracked by Wall St. Rank hold STAB as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 41 Statera Biopharma, Inc. Common Stock shares in Q3 2014, an estimated $393.
  • BNP Paribas Financial Markets first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Statera Biopharma, Inc. Common Stock position peaked at $958 in Q4 2013.
  • 25 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.